Lipidation

Lipidation refers to the covalent attachment of lipid groups to proteins or peptides, altering their physicochemical properties, localisation, and biological behaviour. This modification can occur naturally as a post-translational event, or it can be engineered intentionally to enhance therapeutic performance. Lipidation often increases hydrophobicity and promotes association with cell membranes or carrier proteins, influencing distribution, stability, and half-life. Common lipid modifications include palmitoylation, myristoylation, and engineered fatty acid conjugation.

The biopharmaceutical industry uses lipidation strategically to improve pharmacokinetics and enable less frequent dosing for peptide and protein therapeutics. Lipidated peptides can bind serum albumin, reducing renal clearance and prolonging circulation time, thereby improving patient convenience and adherence. Manufacturing requires careful control to ensure consistent conjugation patterns, as lipid heterogeneity can affect potency, stability, and immunogenicity. Analytical characterisation typically includes mass spectrometry, chromatography, and bioactivity assays to confirm modification integrity and functional impact. As biologic modalities expand, lipidation remains a powerful formulation and design approach that enhances therapeutic durability without altering core biological mechanisms.